LLY watch $833 then 800 round: Dips to buy for next leg upLLY announced new weight loss drug in pill form.
News created a spike which might retrace some.
$833.38 is high support, 800 well supported by fibs.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.51 USD
10.59 B USD
45.04 B USD
849.99 M
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
FIGI
BBG000BNBDC2
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
LLY bullish reversal confirmed.. BUY BUY BUYLLY bully reversal is absolutely confirmed
We have the following confirmations
1) closed above 20 day EMA
2) closed above 50 day EMA
3) closed above 200 day EMA
4) RSI above 60
wait till another candle closes above 200 day EMA
Buy at 866
Stop loss @ 790
TP @ 964
LLY LONG D/WLLY is in an uptrend and this is the weekly trend line. It is likely to make a low and move up to fill the gap. My good friend, I would be happy if you would follow me and leave me a comment.
LLY possible buy trend This chart highlights a recent price breakout followed by a pullback into consolidation.
Key indicators in play:
✅ EMA 9/20/56: Price is currently trading below all EMAs, showing fading momentum. The EMAs are curling down, suggesting short-term weakness or cooling after a strong move.
🟣 SMA 50 & 2
LLY spot buy cycle LLY
Spot
Buy cycle
TP@880.65
% bubble ratio
Currently in a buying cycle (negative bubble) with fair value at 880.65
Spot trading plan:
Entry: Start to buy from -50% bubble ratio and below
Exit: TP at 880.65
Eli Lilly: Catch the Knife or Wait for Support?LLY Just Dropped — Opportunity or Trap?
🔥 LLY (Eli Lilly) is on every trader’s radar! With biotech momentum and blockbuster drug potential, this stock is ready to rip once the dust settles. Smart money is eyeing key zones for a golden entry. 💊📈
📉 New Entry Zones:
🔥 630.00 – Solid buy level
🔥 550.0
ELI LILLY: The time to buy and target 1,300 is now.Eli Lilly is neutral on its 1D technical outlook (RSI = 48.409, MACD = -5.160, ADX = 28.927) and this is technically the most efficient level to buy for the long term towards the end of the year, as the price is sitting around its 1W MA50. The macro pattern is a Channel Up starting back in March 201
Short LLY at 910 Target 780. (Stop on a daily close above 912)Id like to take a swing short on LLY due to its failed breakout and mini head and shoulders pattern. Enter at 910 with a stop on a daily close above 912. Target is 870.
Thanks
Kavi
Eli Lilly Hit Resistance. LLYMy last idea on LLY proved to be very profitable, so here are the early signs of a pivot at hand. Technically, the indicators flipped almost in unison, MIDAS crossed. And just look at that fat bearish candle setting the tone. It is this constellation of factors that gives one confidence to profit fr
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
ELI LILLY 21/43Yield to maturity
7.68%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.19%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.17%
Maturity date
Sep 15, 2060
LLYC
ELI LILLY 15/25Yield to maturity
6.62%
Maturity date
Jun 1, 2025
US532457AM0
ELI LILLY 2025Yield to maturity
6.53%
Maturity date
Jun 1, 2025
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.11%
Maturity date
Mar 1, 2045
US532457BU1
ELI LILLY 19/59Yield to maturity
6.11%
Maturity date
Mar 15, 2059
US532457BT4
ELI LILLY 19/49Yield to maturity
6.10%
Maturity date
Mar 15, 2049
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.08%
Maturity date
May 15, 2047
US532457BS6
ELI LILLY 19/39Yield to maturity
6.01%
Maturity date
Mar 15, 2039
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
5.79%
Maturity date
Feb 27, 2063
See all LLY bonds
Curated watchlists where LLY is featured.
Related stocks
Frequently Asked Questions
The current price of LLY is 884.54 USD — it has increased by 2.89% in the past 24 hours. Watch Eli Lilly and Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Eli Lilly and Company stocks are traded under the ticker LLY.
LLY stock has risen by 5.20% compared to the previous week, the month change is a 4.59% rise, over the last year Eli Lilly and Company has showed a 22.01% increase.
We've gathered analysts' opinions on Eli Lilly and Company future price: according to them, LLY price has a max estimate of 1,190.00 USD and a min estimate of 800.00 USD. Watch LLY chart and read a more detailed Eli Lilly and Company stock forecast: see what analysts think of Eli Lilly and Company and suggest that you do with its stocks.
LLY stock is 4.06% volatile and has beta coefficient of 0.81. Track Eli Lilly and Company stock price on the chart and check out the list of the most volatile stocks — is Eli Lilly and Company there?
Today Eli Lilly and Company has the market capitalization of 815.01 B, it has increased by 14.68% over the last week.
Yes, you can track Eli Lilly and Company financials in yearly and quarterly reports right on TradingView.
Eli Lilly and Company is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 5.32 USD per share, whereas the estimation was 5.04 USD resulting in a 5.45% surprise. The estimated earnings for the next quarter are 3.45 USD per share. See more details about Eli Lilly and Company earnings.
Eli Lilly and Company revenue for the last quarter amounts to 13.53 B USD, despite the estimated figure of 13.47 B USD. In the next quarter, revenue is expected to reach 12.67 B USD.
LLY net income for the last quarter is 4.41 B USD, while the quarter before that showed 970.30 M USD of net income which accounts for 354.48% change. Track more Eli Lilly and Company financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.50 USD. As of today, Dividend Yield (TTM)% is 0.63%. Tracking Eli Lilly and Company dividends might help you take more informed decisions.
Eli Lilly and Company dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 26, 2025, the company has 47 K employees. See our rating of the largest employees — is Eli Lilly and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eli Lilly and Company EBITDA is 18.81 B USD, and current EBITDA margin is 41.75%. See more stats in Eli Lilly and Company financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eli Lilly and Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eli Lilly and Company technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eli Lilly and Company stock shows the buy signal. See more of Eli Lilly and Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.